30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Adaptimmune Therapeutics PLC (ADAP)

Track

Stock chart
Ticker: ADAP Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Wood Gavin
Chief Financial Officer
1 sale — total 950 USD
Sale 2 Sep 2025
Value US$188,759.87 | Price 469.06 | Shares 11,386
Proposed sale 2 Sep 2025
Value US$3,992,093.12 | Price 339.35 | Shares 63,879
Proposed sale 28 Aug 2025
Value US$2,070.00 | Price 0.06 | Shares 34,500
Sale 28 Aug 2025
Value US$2,090.70 | Price 0.01 | Shares 207,000
Sale 18 Aug 2025
Value US$176,061.53 | Price 0.01 | Shares 14,671,794
Sale 15 Aug 2025
Value US$53,110.27 | Price 0.01 | Shares 4,828,206
Proposed sale 15 Aug 2025
Value US$981,914.00 | Price 0.07 | Shares 13,829,778
Proposed sale 15 Aug 2025
Value US$230,750.00 | Price 0.07 | Shares 3,250,000
Sale 30 Jul 2025
Value US$2,800,943.81 | Price 0.10 | Shares 27,433,338
Sale 29 Jul 2025
Value US$271,970.95 | Price 0.10 | Shares 2,687,460
Sale 28 Jul 2025
Value US$3,817,320.75 | Price 0.11 | Shares 33,931,740
Proposed sale 17 Jan 2025
Value US$3,243.00 | Price 0.58 | Shares 5,584
Sale 17 Jan 2025
Value US$3,243.19 | Price 0.58 | Shares 5,584
Proposed sale 17 Jan 2025
Value US$3,243.00 | Price 0.58 | Shares 5,584
Sale 17 Jan 2025
Value US$3,243.19 | Price 0.58 | Shares 5,584
Proposed sale 17 Jan 2025
Value US$3,243.00 | Price 0.58 | Shares 5,584
Sale 17 Jan 2025
Value US$3,243.19 | Price 0.58 | Shares 5,584
Proposed sale 17 Jan 2025
Value US$17,772.00 | Price 0.58 | Shares 30,601
Sale 17 Jan 2025
Value US$17,773.06 | Price 0.58 | Shares 30,601
Proposed sale 15 Jan 2025
Value US$5,635.00 | Price 0.57 | Shares 9,803
Sale 15 Jan 2025
Value US$5,634.76 | Price 0.57 | Shares 9,803
Proposed sale 15 Jan 2025
Value US$7,467.00 | Price 0.57 | Shares 12,991
Sale 15 Jan 2025
Value US$7,467.23 | Price 0.57 | Shares 12,991
Proposed sale 15 Jan 2025
Value US$5,635.00 | Price 0.57 | Shares 9,803
Sale 15 Jan 2025
Value US$5,634.76 | Price 0.57 | Shares 9,803
Proposed sale 15 Jan 2025
Value US$5,635.00 | Price 0.57 | Shares 9,803
Sale 15 Jan 2025
Value US$5,634.76 | Price 0.57 | Shares 9,803
Proposed sale 15 Jan 2025
Value US$16,724.00 | Price 0.57 | Shares 29,096
Sale 15 Jan 2025
Value US$16,724.38 | Price 0.57 | Shares 29,096
Proposed sale 13 Jan 2025
Value US$5,726.00 | Price 0.59 | Shares 9,739
Sale 13 Jan 2025
Value US$3,216.40 | Price 0.59 | Shares 5,471
Sale 13 Jan 2025
Value US$2,509.16 | Price 0.59 | Shares 4,268
Proposed sale 13 Jan 2025
Value US$7,286.00 | Price 0.59 | Shares 12,392
Sale 13 Jan 2025
Value US$4,776.10 | Price 0.59 | Shares 8,124
Sale 13 Jan 2025
Value US$2,509.16 | Price 0.59 | Shares 4,268
Proposed sale 13 Jan 2025
Value US$5,726.00 | Price 0.59 | Shares 9,739
Sale 13 Jan 2025
Value US$3,216.40 | Price 0.59 | Shares 5,471
Sale 13 Jan 2025
Value US$2,509.16 | Price 0.59 | Shares 4,268
Proposed sale 13 Jan 2025
Value US$17,917.00 | Price 0.59 | Shares 30,473
Sale 13 Jan 2025
Value US$10,543.40 | Price 0.59 | Shares 17,934
Sale 13 Jan 2025
Value US$7,371.68 | Price 0.59 | Shares 12,539
Sale 18 Jun 2024
Value US$22,813.83 | Price 0.93 | Shares 24,531
Sale 17 Jan 2024
Value US$8,726.79 | Price 0.67 | Shares 12,967
Sale 17 Jan 2024
Value US$3,572.96 | Price 0.67 | Shares 5,309
Sale 17 Jan 2024
Value US$8,617.76 | Price 0.67 | Shares 12,805
Sale 17 Jan 2024
Value US$3,572.96 | Price 0.67 | Shares 5,309
Sale 17 Jan 2024
Value US$20,243.84 | Price 0.67 | Shares 30,080
Sale 17 Jan 2024
Value US$9,152.13 | Price 0.67 | Shares 13,599
Sale 17 Jan 2024
Value US$3,572.96 | Price 0.67 | Shares 5,309
Sale 16 Jan 2024
Value US$1,806.73 | Price 0.79 | Shares 2,287
Sale 16 Jan 2024
Value US$3,697.99 | Price 0.79 | Shares 4,681
Sale 16 Jan 2024
Value US$7,350.16 | Price 0.79 | Shares 9,304
Sale 16 Jan 2024
Value US$3,697.99 | Price 0.79 | Shares 4,681
Sale 12 Jan 2024
Value US$4,458.40 | Price 0.85 | Shares 5,220
Sale 12 Jan 2024
Value US$6,661.13 | Price 0.85 | Shares 7,799
Sale 12 Jan 2024
Value US$14,739.20 | Price 0.85 | Shares 17,257
Sale 12 Jan 2024
Value US$4,458.40 | Price 0.85 | Shares 5,220
Sale 11 Jan 2024
Value US$3,354.33 | Price 0.84 | Shares 4,009
Sale 11 Jan 2024
Value US$3,354.33 | Price 0.84 | Shares 4,009
Sale 11 Jan 2024
Value US$9,994.38 | Price 0.84 | Shares 11,945
Sale 11 Jan 2024
Value US$3,354.33 | Price 0.84 | Shares 4,009
Sale 1 Sep 2023
Value US$1,874.34 | Price 0.78 | Shares 2,403
Sale 1 Aug 2023
Value US$2,803.74 | Price 0.91 | Shares 3,096
Sale 10 Jul 2023
Value US$43,446.98 | Price 0.91 | Shares 47,702
Sale 27 Jun 2023
Value US$2,146.36 | Price 0.92 | Shares 2,333
Sale 31 Jan 2023
Value US$22,229.54 | Price 1.87 | Shares 11,890
Sale 17 Jan 2023
Value US$4,011.42 | Price 1.86 | Shares 2,159
Sale 17 Jan 2023
Value US$8,249.52 | Price 1.86 | Shares 4,440
Sale 17 Jan 2023
Value US$8,249.52 | Price 1.86 | Shares 4,440
Sale 17 Jan 2023
Value US$18,685.91 | Price 1.86 | Shares 10,057
Sale 12 Jan 2023
Value US$12,707.99 | Price 1.71 | Shares 7,449
Sale 12 Jan 2023
Value US$8,483.94 | Price 1.71 | Shares 4,973
Sale 12 Jan 2023
Value US$8,483.94 | Price 1.71 | Shares 4,973
Sale 12 Jan 2023
Value US$32,009.68 | Price 1.71 | Shares 18,763
Sale 11 Jan 2023
Value US$6,712.95 | Price 1.75 | Shares 3,843
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-09-03 2025-09-02 S Sale
Wood Gavin

Chief Financial Officer

Officer
11,386 +7.2%
469.06
US$188,760 		11,386 +7.2% 469.06 US$188,760
2025-09-02 2025-09-02 PrS Proposed sale
Gavin Wood

Chief Financial Officer

Officer
63,879
339.35
US$3,992,093 		63,879 339.35 US$3,992,093
2025-08-29 2025-08-28 PrS Proposed sale
3.5
William Bertrand

Chief Operating Officer

Officer
67,585
57.12
US$1,329,352 		67,585 57.12 US$1,329,352
2025-08-29 2025-08-28 S Sale
3.5
Bertrand William C JR

Chief Operating Officer

Officer
207,000 -17.3%
0.01
US$2,091 		207,000 -17.3% 0.01 US$2,091
2025-08-19 2025-08-18 S Sale
1.5
Behbahani Ali
Non-Executive Director
14,671,794 -100.0%
0.01
US$176,062 		14,671,794 -100.0% 0.01 US$176,062
2025-08-19 2025-08-15 S Sale
1.5
Behbahani Ali
Non-Executive Director
4,828,206 -24.8%
0.01
US$53,110 		4,828,206 -24.8% 0.01 US$53,110
2025-08-15 2025-08-15 PrS Proposed sale
2.4
New Enterprise Associates, 14 LP

Affiliate
13,829,778
0.07
US$981,914 		13,829,778 0.07 US$981,914
2025-08-15 2025-08-15 PrS Proposed sale
2.4
New Enterprise Associates, 16 LP

Affiliate
3,250,000
0.07
US$230,750 		3,250,000 0.07 US$230,750
2025-07-30 2025-07-30 S Sale
3.1
EcoR1 Capital, LLC
Large shareholder
27,433,338 -21.5%
0.10
US$2,800,944 		27,433,338 -21.5% 0.10 US$2,800,944
2025-07-30 2025-07-29 S Sale
3.1
EcoR1 Capital, LLC
Large shareholder
2,687,460 -2.1%
0.10
US$271,971 		2,687,460 -2.1% 0.10 US$271,971
2025-07-30 2025-07-28 S Sale
3.1
EcoR1 Capital, LLC
Large shareholder
33,931,740 -20.6%
0.11
US$3,817,321 		33,931,740 -20.6% 0.11 US$3,817,321
2025-01-17 2025-01-17 PrS Proposed sale
3.4
Norry Elliot

Chief Medical Officer

Officer
5,584
0.58
US$3,243 		5,584 0.58 US$3,243
2025-01-17 2025-01-17 PrS Proposed sale
3.7
Lunger John

Chief Patient Supply Officer

Officer
5,584
0.58
US$3,243 		5,584 0.58 US$3,243
2025-01-17 2025-01-17 PrS Proposed sale
3.5
Bertrand William C JR

Chief Operating Officer

Officer
5,584
0.58
US$3,243 		5,584 0.58 US$3,243
2025-01-17 2025-01-17 PrS Proposed sale
3.0
Rawcliffe Adrian

Chief Executive Officer

Officer
30,601
0.58
US$17,772 		30,601 0.58 US$17,772
2025-01-17 2025-01-17 S Sale
3.0
Rawcliffe Adrian

Chief Executive Officer

Executive Director
30,601 -40.8%
0.58
US$17,773 		30,601 -40.8% 0.58 US$17,773
2025-01-17 2025-01-17 S Sale
3.4
Norry Elliot

Chief Medical Officer

Officer
5,584 -42.6%
0.58
US$3,243 		5,584 -42.6% 0.58 US$3,243
2025-01-17 2025-01-17 S Sale
3.7
Lunger John

Chief Patient Supply Officer

Officer
5,584 -42.6%
0.58
US$3,243 		5,584 -42.6% 0.58 US$3,243
2025-01-17 2025-01-17 S Sale
3.5
Bertrand William C JR

Chief Operating Officer

Officer
5,584 -42.6%
0.58
US$3,243 		5,584 -42.6% 0.58 US$3,243
2025-01-15 2025-01-15 PrS Proposed sale
3.5
Bertrand William C JR

Chief Operating Officer

Officer
9,803
0.57
US$5,635 		9,803 0.57 US$5,635
2025-01-15 2025-01-15 PrS Proposed sale
2.9
Piccina Cintia

Chief Commercial Officer

Officer
12,991
0.57
US$7,467 		12,991 0.57 US$7,467
2025-01-15 2025-01-15 PrS Proposed sale
3.4
Norry Elliot

Chief Medical Officer

Officer
9,803
0.57
US$5,635 		9,803 0.57 US$5,635
2025-01-15 2025-01-15 PrS Proposed sale
3.7
Lunger John

Chief Patient Supply Officer

Officer
9,803
0.57
US$5,635 		9,803 0.57 US$5,635
2025-01-15 2025-01-15 PrS Proposed sale
3.0
Rawcliffe Adrian

Chief Executive Officer

Officer
29,096
0.57
US$16,724 		29,096 0.57 US$16,724
2025-01-15 2025-01-15 S Sale
3.0
Rawcliffe Adrian

Chief Executive Officer

Executive Director
29,096 -41.2%
0.57
US$16,724 		29,096 -41.2% 0.57 US$16,724
2025-01-15 2025-01-15 S Sale
3.5
Bertrand William C JR

Chief Operating Officer

Officer
9,803 -41.6%
0.57
US$5,635 		9,803 -41.6% 0.57 US$5,635
2025-01-15 2025-01-15 S Sale
3.4
Norry Elliot

Chief Medical Officer

Officer
9,803 -41.6%
0.57
US$5,635 		9,803 -41.6% 0.57 US$5,635
2025-01-15 2025-01-15 S Sale
3.7
Lunger John

Chief Patient Supply Officer

Officer
9,803 -41.6%
0.57
US$5,635 		9,803 -41.6% 0.57 US$5,635
2025-01-15 2025-01-15 S Sale
2.9
Piccina Cintia

Chief Commercial Officer

Officer
12,991 -41.4%
0.57
US$7,467 		12,991 -41.4% 0.57 US$7,467
2025-01-15 2025-01-13 PrS Proposed sale
3.5
Bertrand William C JR

Chief Operating Officer

Officer
9,739
0.59
US$5,726 		9,739 0.59 US$5,726
2025-01-15 2025-01-13 PrS Proposed sale
3.4
Norry Elliot

Chief Medical Officer

Officer
12,392
0.59
US$7,286 		12,392 0.59 US$7,286
2025-01-15 2025-01-13 PrS Proposed sale
3.7
Lunger John

Chief Patient Supply Officer

Officer
9,739
0.59
US$5,726 		9,739 0.59 US$5,726
2025-01-15 2025-01-13 PrS Proposed sale
3.0
Rawcliffe Adrian

Chief Executive Officer

Officer
30,473
0.59
US$17,917 		30,473 0.59 US$17,917
2025-01-15 2025-01-13 S Sale
3.0
Rawcliffe Adrian

Chief Executive Officer

Executive Director
17,934 -41.1%
0.59
US$10,543 		17,934 -41.1% 0.59 US$10,543
2025-01-15 2025-01-13 S Sale
3.0
Rawcliffe Adrian

Chief Executive Officer

Executive Director
12,539 -41.3%
0.59
US$7,372 		12,539 -41.3% 0.59 US$7,372
2025-01-15 2025-01-13 S Sale
3.5
Bertrand William C JR

Chief Operating Officer

Officer
5,471 -41.8%
0.59
US$3,216 		5,471 -41.8% 0.59 US$3,216
2025-01-15 2025-01-13 S Sale
3.5
Bertrand William C JR

Chief Operating Officer

Officer
4,268 -42.2%
0.59
US$2,509 		4,268 -42.2% 0.59 US$2,509
2025-01-15 2025-01-13 S Sale
3.4
Norry Elliot

Chief Medical Officer

Officer
8,124 -41.4%
0.59
US$4,776 		8,124 -41.4% 0.59 US$4,776
2025-01-15 2025-01-13 S Sale
3.4
Norry Elliot

Chief Medical Officer

Officer
4,268 -42.2%
0.59
US$2,509 		4,268 -42.2% 0.59 US$2,509
2025-01-15 2025-01-13 S Sale
3.7
Lunger John

Chief Patient Supply Officer

Officer
5,471 -41.8%
0.59
US$3,216 		5,471 -41.8% 0.59 US$3,216
2025-01-15 2025-01-13 S Sale
3.7
Lunger John

Chief Patient Supply Officer

Officer
4,268 -42.2%
0.59
US$2,509 		4,268 -42.2% 0.59 US$2,509
2024-06-18 2024-06-18 S Sale
2.9
Piccina Cintia

Chief Commercial Officer

Officer
24,531 -39.0%
0.93
US$22,814 		24,531 -39.0% 0.93 US$22,814
2024-01-17 2024-01-17 S Sale
3.4
Norry Elliot

Chief Medical Officer

Officer
12,967 -40.2%
0.67
US$8,727 		12,967 -40.2% 0.67 US$8,727
2024-01-17 2024-01-17 S Sale
3.4
Norry Elliot

Chief Medical Officer

Officer
5,309 -40.5%
0.67
US$3,573 		5,309 -40.5% 0.67 US$3,573
2024-01-17 2024-01-17 S Sale
3.7
Lunger John

Chief Patient Supply Officer

Officer
12,805 -40.2%
0.67
US$8,618 		12,805 -40.2% 0.67 US$8,618
2024-01-17 2024-01-17 S Sale
3.7
Lunger John

Chief Patient Supply Officer

Officer
5,309 -40.5%
0.67
US$3,573 		5,309 -40.5% 0.67 US$3,573
2024-01-17 2024-01-17 S Sale
3.0
Rawcliffe Adrian

Chief Executive Officer

Executive Director
30,080 -40.1%
0.67
US$20,244 		30,080 -40.1% 0.67 US$20,244
2024-01-17 2024-01-17 S Sale
3.5
Bertrand William C JR

Chief Operating Officer

Officer
13,599 -40.2%
0.67
US$9,152 		13,599 -40.2% 0.67 US$9,152
2024-01-17 2024-01-17 S Sale
3.5
Bertrand William C JR

Chief Operating Officer

Officer
5,309 -40.5%
0.67
US$3,573 		5,309 -40.5% 0.67 US$3,573
2024-01-17 2024-01-16 S Sale
3.4
Norry Elliot

Chief Medical Officer

Officer
2,287 -40.5%
0.79
US$1,807 		2,287 -40.5% 0.79 US$1,807
2024-01-17 2024-01-16 S Sale
3.7
Lunger John

Chief Patient Supply Officer

Officer
4,681 -40.0%
0.79
US$3,698 		4,681 -40.0% 0.79 US$3,698
2024-01-17 2024-01-16 S Sale
3.0
Rawcliffe Adrian

Chief Executive Officer

Executive Director
9,304 -39.7%
0.79
US$7,350 		9,304 -39.7% 0.79 US$7,350
2024-01-17 2024-01-16 S Sale
3.5
Bertrand William C JR

Chief Operating Officer

Officer
4,681 -40.0%
0.79
US$3,698 		4,681 -40.0% 0.79 US$3,698
2024-01-12 2024-01-12 S Sale
3.7
Lunger John

Chief Patient Supply Officer

Officer
5,220 -39.9%
0.85
US$4,458 		5,220 -39.9% 0.85 US$4,458
2024-01-12 2024-01-12 S Sale
3.4
Norry Elliot

Chief Medical Officer

Officer
7,799 -39.7%
0.85
US$6,661 		7,799 -39.7% 0.85 US$6,661
2024-01-12 2024-01-12 S Sale
3.0
Rawcliffe Adrian

Chief Executive Officer

Executive Director
17,257 -39.5%
0.85
US$14,739 		17,257 -39.5% 0.85 US$14,739
2024-01-12 2024-01-12 S Sale
3.5
Bertrand William C JR

Chief Operating Officer

Officer
5,220 -39.9%
0.85
US$4,458 		5,220 -39.9% 0.85 US$4,458
2024-01-12 2024-01-11 S Sale
3.7
Lunger John

Chief Patient Supply Officer

Officer
4,009 -39.6%
0.84
US$3,354 		4,009 -39.6% 0.84 US$3,354
2024-01-12 2024-01-11 S Sale
3.4
Norry Elliot

Chief Medical Officer

Officer
4,009 -39.6%
0.84
US$3,354 		4,009 -39.6% 0.84 US$3,354
2024-01-12 2024-01-11 S Sale
3.0
Rawcliffe Adrian

Chief Executive Officer

Executive Director
11,945 -39.4%
0.84
US$9,994 		11,945 -39.4% 0.84 US$9,994
2024-01-12 2024-01-11 S Sale
3.5
Bertrand William C JR

Chief Operating Officer

Officer
4,009 -39.6%
0.84
US$3,354 		4,009 -39.6% 0.84 US$3,354
2023-09-01 2023-09-01 S Sale
3.0
Rawcliffe Adrian

Chief Executive Officer

Executive Director
2,403 -41.1%
0.78
US$1,874 		2,403 -41.1% 0.78 US$1,874
2023-08-01 2023-08-01 S Sale
3.7
Lunger John

Chief Patient Supply Officer

Officer
3,096 -39.6%
0.91
US$2,804 		3,096 -39.6% 0.91 US$2,804
2023-07-10 2023-07-10 S Sale
3.2
Menzel Garry E
Non-Executive Director
47,702 -38.9%
0.91
US$43,447 		47,702 -38.9% 0.91 US$43,447
2023-06-27 2023-06-27 S Sale
3.0
Rawcliffe Adrian

Chief Executive Officer

Executive Director
2,333 -39.9%
0.92
US$2,146 		2,333 -39.9% 0.92 US$2,146
2023-01-31 2023-01-31 S Sale
2.9
Piccina Cintia

Chief Commercial Officer

Officer
11,890 -37.8%
1.87
US$22,230 		11,890 -37.8% 1.87 US$22,230
2023-01-17 2023-01-17 S Sale
3.4
Norry Elliot

Chief Medical Officer

Officer
2,159 -38.2%
1.86
US$4,011 		2,159 -38.2% 1.86 US$4,011
2023-01-17 2023-01-17 S Sale
3.7
Lunger John

Chief Patient Supply Officer

Officer
4,440 -37.9%
1.86
US$8,250 		4,440 -37.9% 1.86 US$8,250
2023-01-17 2023-01-17 S Sale
3.5
Bertrand William C JR

Chief Operating Officer

Officer
4,440 -37.9%
1.86
US$8,250 		4,440 -37.9% 1.86 US$8,250
2023-01-17 2023-01-17 S Sale
3.0
Rawcliffe Adrian

Chief Executive Officer

Executive Director
10,057 -43.0%
1.86
US$18,686 		10,057 -43.0% 1.86 US$18,686
2023-01-12 2023-01-12 S Sale
3.4
Norry Elliot

Chief Medical Officer

Officer
7,449 -37.9%
1.71
US$12,708 		7,449 -37.9% 1.71 US$12,708
2023-01-12 2023-01-12 S Sale
3.7
Lunger John

Chief Patient Supply Officer

Officer
4,973 -38.0%
1.71
US$8,484 		4,973 -38.0% 1.71 US$8,484
2023-01-12 2023-01-12 S Sale
3.5
Bertrand William C JR

Chief Operating Officer

Officer
4,973 -38.0%
1.71
US$8,484 		4,973 -38.0% 1.71 US$8,484
2023-01-12 2023-01-12 S Sale
3.0
Rawcliffe Adrian

Chief Executive Officer

Executive Director
18,763 -43.0%
1.71
US$32,010 		18,763 -43.0% 1.71 US$32,010
2023-01-12 2023-01-11 S Sale
3.4
Norry Elliot

Chief Medical Officer

Officer
3,843 -38.0%
1.75
US$6,713 		3,843 -38.0% 1.75 US$6,713
Explore more

More insider trading research around Adaptimmune Therapeutics PLC

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America